Real-time enrollment status for this ebv clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:54 PM UTC
| NCT Number | NCT06908096 |
| Recruiting Status | Recruiting |
| Condition | EBV |
| Phase | PHASE1 |
| Target Enrollment | 750 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | May 18, 2026 (May 18, 2026) |
As of July 16, 2026: Clinical trial NCT06908096 is currently recruiting participants. This phase1 study for ebv is actively seeking new participants at 1 location across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06908096 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06908096 was last updated May 18, 2026 (May 18, 2026). HelloStudys verifies this status automatically.